Purpose: Summarize and appraise an article for bias and validity in a collaborative environment.
Assessment: The DBs are worth 38 points. It will be graded based quality of 3 posts made on 3 different days. Please see the grading rubric embedded below for complete criteria.
Instructions: Carefully read, summarize, and appraise your group’s assigned article. The discussion board for this week should cover the following concepts in order to have a complete draft by the end of the week. Apply the concepts discussed in the lecture and the readings. As you provide input to your peers, be sure to state a rationale for your claims.
1. Identify and discuss the following:
a. measurement instruments, what they measured, and how/when/where the data was collected
b. the intervention and how it was carried out (description of intervention, who/when/where the intervention was applied)
2. Appraise and debate the quality of the data collection methods and determine whether the conclusions of the study were supported by the statistical results. Consider the following questions:
a. Was treatment fidelity ensured? Why or why not?
b. Were the measurement instruments reliable and valid? Why or why not?
c. Were the conclusions of the study supported by the results? Why or why not?
- Include key statistical results and p-values as part of your rationale.
- RubricAssessment-NUR4440-02_ResearchinNursing2021FallTerm2-14108-ResurrectionUniversity.pdf
- essentialoilsforPONV.pdf
Research Discussion Board Rubric Course: NUR4440-02:Research in Nursing (2021 Fall Term 2)-14108
Criteria Advanced Proficient Developing Incomplete Unsatisfactory Criterion Score
Word Count: 100
word minimum
(artificial filler
(adding citations,
thank you’s to
peers, etc. will not
be counted)
/ 3
Number of posts
(Posts must meet
quality criterion
to count for this
criterion.)
/ 5
Clustering of
posts (Post must
meet quality
criterion to count
for this criterion.)
/ 10
3 points
Criterion met for ALL
posts
0 points 0 points 0 points 0 points
Criterion NOT met
for ANY ONE post.
5 points
at least 3 posts
4.5 points
at least 2 posts
4 points
at least 1 post
0 points 0 points
no posts
10 points
posts made on 3
separate days
9 points
posts made on 2
separate days
8 points
posts made on 1 day
0 points 0 points
no posts
Total / 38
Criteria Advanced Proficient Developing Incomplete Unsatisfactory Criterion Score
Posts meet ALL of
the following:
answers part of
the prompt not
previously
answered;
rationale is given;
not repetitive
with own or
others’ posts;
stays on topic of
thread;
information
relates to the
article; attempts
to apply concepts
intro’d in lecture
/ 2020 points
3 posts meet criteria
17 points
2 posts meet criteria
14 points
1 post meets criteria
10 points
no posts meet
criteria, but posts are
made
0 points
no posts made
Overall Score
Advanced 35 points minimum
Proficient 32 points minimum
Developing 29 points minimum
Unsatisfactory 28 points minimum
,
ORIGINAL ARTICLE
Essential Oils to Reduce Postoperative Nausea and Vomiting
Maxine A. Fearrington, MS, RN-BC, Brandon W. Qualls, MPA,
Mary G. Carey, PhD, RN, FAHA, FAAN
Purpose: The purpose of this study was to determine if using essential oil
Maxine A. Fearr
University of Roch
don W. Qualls, MPA
sity of Rochester M
Carey, PhD, RN, FA
ter, University of R
Conflict of intere
conflict of interest
research because s
dustry selling essen
However, for this
from a company
Qualls and Mary G
Address corresp
Surgical Center, U
Elmwood Avenue
maxine_fearringto
Published by Els
PeriAnesthesia Nu
1089-9472/$36.
https://doi.org/1
Journal of PeriAnesth
products for adult patients reduced the need for antiemetics for postoper-
ative nausea and vomiting (PONV). Design: A prospective and retrospective cross-sectional design using a con-
venience sample. Methods: Double blinded to the type of essential oil, subjects randomly
selected a nasal inhaler containing peppermint, ginger, or a combination
of both. A prophylactic dose was given preoperatively, and during the
postoperative period nausea was assessed using verbal descriptive scale. Findings: Overall 322 same day surgical patients were analyzed (control
group [n 5 179] and intervention group [n 5 143]). The intervention group had a greater history of PONV but received fewer doses of anti-
emetics postoperatively compared with the control group. There was no
significant difference in the effectiveness of the three types of inhalers. Conclusions: Aromatherapy demonstrated a statistically significant (P , .05) reduction in the need for antiemetics to treat PONV.
Keywords: aromatherapy, postoperative nausea, hospital, surgical center.
Published by Elsevier, Inc. on behalf of American Society of PeriAnesthesia
Nurses
ington, MS, RN-BC, Strong Surgical Center,
ester Medical Center, Rochester, NY; Bran-
, Clinical Nursing Research Center, Univer-
edical Center, Rochester, NY; and Mary G.
HA, FAAN, Clinical Nursing Research Cen-
ochester Medical Center, Rochester, NY.
st: Maxine A. Fearrington has an apparent
which may question the objectivity of the
he in an independent consultant to the in-
tial oils, the intervention for this protocol.
protocol, the intervention product comes
she has no association with. Brandon W.
. Carey have no conflicts of interest.
ondence to Maxine A. Fearrington, Strong
niversity of Rochester Medical Center, 601
, Rochester, NY 14642; e-mail address:
[email protected]
evier, Inc. on behalf of American Society of
rses
00
0.1016/j.jopan.2019.01.010
esia Nursing, Vol -, No – (-), 2019: pp 1-7
PATIENTS ANTICIPATING SURGERY typically experience some degree of anxiety related to the potential for experiencing unpleasant side effects
such as postoperative nausea and vomiting
(PONV). Traditional interventions to treat PONV
involve administering intravenous (IV) antiemetics.
However, pharmacologic therapies can be accom-
panied by adverse consequences including seda-
tion, alterations in heart rate or rhythm, decreased
level of consciousness, and an increased demand on nursing care.
1-3 Aromatherapy offers an
alternative or complimentary therapy that can be
either nurse or patient administered.
Literature Review
Currently, aromatherapy is used in a variety of
clinical settings and for a variety of purposes. Also referred to as essential oils, aromatherapy is
most frequently used to manage nausea, 1-10
1
2 FEARRINGTON, QUALLS, AND CAREY
pain, 6
insomnia, 6
and stress or anxiety. 11,12
Essential oils are concentrated essence extracted
from plants using a distillation process. 13
Reis
and Jones caution that not all essential oils are
created equally; consumers (nurses) should pur- chase and use oils that meet the criteria for thera-
peutic or medicinal quality. Many oils may be
certified pure and organic, which means they
may meet established guidelines, yet the therapeu-
tic effect may be in question. 13
When the right oils
are used for the right reason, and in the right way,
many beneficial outcomes can be realized.
One example of a beneficial use of aromatherapy is
to reduce anxiety. Stress and anxiety are often pre-
sent in many hospitalized patients and can lead to
undesirable outcomes. Bikmoradi et al studied the
effects of inhaled lavender essential oils on the vital
signs of 60 patients undergoing coronary bypass
surgery. 11
This study examined changes in mental
stress using both a Depression Anxiety Stress Scale (DASS-21) questionnaire and changes in vital signs.
The results were not statistically significant for the
intervention group, except for an increase in sys-
tolic blood pressure at 5 and 30 minutes postinter-
vention. At the 5-minute mark on the third day
postprocedure, systolic blood pressure for the con-
trol group (114 6 20) was lower than the interven- tion group (127 6 25), and at the 30-minute mark, similar results were noted (116 6 22 and 131 6 25, respectively). Despite the lack of positive evidence, Bikmoradi et al
11 recommended lavender
as a low cost, minimal risk intervention for use that
may help in decreasing anxiety and mental stress.
These contradictory results demonstrate the need
for further studies in this area.
Another study examined women undergoing breast
biopsies (n 5 87) and the effects of aromatherapy on anxiety levels. Trambert et al
12 compared
lavender-sandalwood and orange-peppermint
essential oils against a placebo, which revealed sta-
tistically significant results for women in the
lavender-sandalwood blend group at reducing anxi-
ety. This study was a randomized three-arm study measuring anxiety levels using the State-Trait Anxi-
ety Inventory, with the lavender-sandalwood group
being both statistically and clinically significant in
the reduction of postprocedure anxiety.
Johnson et al 6 reported on a retrospective study
(n 5 5,837) where nurses in a large health system
in the mid-west were trained in the use of various
essential oils for use as ‘‘therapeutic interventions’’
as deemed appropriate by the nurses. Symptoms
such as pain, anxiety, and nausea were addressed
using essential oils of sweet marjoram, lavender, mandarin, and ginger, respectively. This study of
nurse-delivered aromatherapy revealed a decrease
in score among the three outcomes; however, pain
scores decreased an average of three points on a
0 to 10 scale, which demonstrated strong evidence
(statistically significant, yet the actual results were
not provided) to support the use of essential oils as
a complement to standard of care in a holistic patient care environment.
6
PONV is a relatively common side effect of surgery;
yet the exact causation is not fully understood. 3 A
number of factors have been identified that can
lead to an increased incidence of PONV, such as fe-
male gender, nonsmoker, a history of PONVor mo-
tion sickness, and surgical procedures lasting greater than 1 hour.
3 Several studies have been
conducted using peppermint, ginger, or various
other combinations for use as prevention or treat-
ment of PONV. 1-10
Two systematic reviews were
published in 2012 examining the use of various
types of inhaled aromatherapy for PONV, 14,15
demonstrating encouraging but not yet
convincing results. However, most of the studies reviewed were small or lacking in rigor. Since
2012, several larger and more compelling studies
have been conducted. Three of the four studies
that tested the use of peppermint oil
demonstrated positive results in reducing
PONV. 1,2,7,10
Similarly, three other studies using
inhaled ginger oil 4,6,8
and three using a
commercially prepared product QueaseEASE 3,9
or a combination of several oils 5 also showed
favorable results in reducing PONV. Despite these
findings, many practitioners still hesitate to
embrace this treatment modality, likely because
of the need for additional research that is more
rigorous in design, 7,8
a larger sample size, 2,3
or
longer in duration. 1,10
Purpose
The purpose of this study was to determine if
aromatherapy (peppermint, ginger, or a combina-
tion) for adult hospital ambulatory or 23-hour
surgical patients would reduce the need for anti-
emetics to treat PONV.
ESSENTIAL OILS FOR NAUSEA AND VOMITING 3
Sample and Setting
The study took place in the surgical center of a
large urban teaching hospital. The target popula-
tion was adult patients scheduled for same day or
short-stay surgical procedures. The intervention
group was a convenience sample, selected from
the operating room schedule that met the initial
criteria of being scheduled for ambulatory surgery
or a 23-hour stay. Most (94.4%) of surgical proced- ures targeted patients in six services including or-
thopaedics, urology, general and trauma, plastics,
neurosurgery, and ear, nose, and throat, with less
than 6% being colorectal and gynecologic sur-
geries. They were then screened using the inclu-
sion criteria of being at least aged 18 years, able
to understand and follow directions, able to give
informed consent, and understand, read, and write English. Patients were excluded if they had a his-
tory of chronic obstructive pulmonary disease,
asthma, or other respiratory disorder that could
be exacerbated by strong odors, inability to smell
fragrances (before or after surgery), allergic or sen-
sitive to either peppermint or ginger, or sensitive
to any strong odors. The control group was a retro-
spective chart review of prior year’s surgeries that met the same initial inclusion criteria (same-day or
23-hour stay) as the intervention group.
Protection of Human Subjects
After receiving Institutional Review Board
approval and registering as a Phase II trial on
clinicaltrials.gov, recruitment of subjects began.
All data were recorded on an encrypted portable
device, and none of the stored data contained
any identifiable information about the research
subjects. Paper copies were stored in a secure loca-
tion, and once all pertinent data were captured, the papers were shredded.
Figure 1. Plastic nasal inhaler sealed in plastic
with unique four-digit number. This image is available
in color online at www.jopan.org.
Methods
For the retrospective chart review, initial selection
of patients was accomplished by the first author by
reviewing retained hard copies of operating room
schedules from July through December 2017, of
patients who had ambulatory surgery or stayed in
the 23-hour unit postoperatively. Once identified,
the patients’ electronic medical records were ac- cessed using a unit-based computer. Data collected
included age, gender, race, type of surgery, length
of stay, history and episodes of PONV, and type and
number of both intraoperative and postoperative
doses of antiemetics administered. These patients
comprised the control group as they received the
standard IV antiemetic medication for any PONV.
Intervention: Essential Oils
The inhalers were premade by designated
personnel (not associated with the surgical center
patients) and contained four drops of essential
oils of peppermint or ginger, or a combination con-
taining two drops of each of the two oils. The in- halers were sealed in plastic shrink-wrap and
marked with a four-digit number, which was re-
corded on a log and held in a separate secure loca-
tion in the surgical center until the study was
complete (Figure 1). The inhalers all looked the
same and the fragrance was undetectable; there-
fore, the study was double blinded to the type of
essential oil.
For the prospective study, all providers and nurses
in the postanesthesia care unit and surgical center
were provided training and material to inform
them of the study protocol. Potential subjects
were identified from the operating room schedule
as meeting the initial criteria. These subjects were
then approached to determine initial interest in study participation. Subjects were then given an
information sheet, and the study protocol ex-
plained. Investigators offered the subjects the
informed consent to read, ask questions, and sign
if participation was desired. Consent forms were
placed in a secure location in the surgical center.
4 FEARRINGTON, QUALLS, AND CAREY
After obtaining informed consent, a color-coded
(blue) wristband was applied to the subject’s wrist
as a visual aid that designated the patient as a study
subject. Several blue dot stickers were also applied
to various locations in the paper chart that accom- panied the subject throughout their hospital stay
as another way to flag the patient as a study sub-
ject. All data were deidentified, and the following
variables were collected: age, gender, race, type
of surgery, length of stay, history and episodes of
PONV, and type and number of doses of anti-
emetics administered. The numeric number from
the blue wristband served as the subject’s unique identifier and was in no way tied to the patient’s
medical record. The subject then selected at
random a nasal inhaler from a basket. The subjects
were instructed to use the inhaler for one dose
(two to three slow deep inhalations from the nasal
inhaler) before receiving any sedating medication
preoperatively. The inhaler was then placed inside
the patient’s paper chart, which accompanied the patient throughout their stay in the hospital.
The nurses in the postanesthesia care unit were
trained to assess nausea with every set of vital
signs, using a 0 to 3 verbal descriptive scale, 5 and
for any score of 1 to 3, offer the subject the nasal
inhaler as the first intervention. Nausea was then
reassessed 5 minutes after inhaler was used, and if nausea was not yet relieved, the subject would
be offered a second dose from the inhaler. The sub-
jects were advised that they could, at any time,
request a dose of ordered medication with or in
place of the nasal inhaler without being unen-
rolled in the study. Any patient who was actively
vomiting was given a dose of ordered medication
without using the inhaler; however, any subse- quent episodes of nausea were encouraged to
use the nasal inhaler before receiving additional
medication.
Analysis Plan
All analyses were conducted using Statistical
Package for the Social Science (SPSS v25 for Windows) and statistical significance was set to P
, .05. Continuous measures (eg, age) were reported as mean 6 standard deviation and categorical variables (eg, gender) as a count (n,
%). Demographic and clinical characteristics of
the groups (ie, control vs intervention) were
compared using Student’s t test to determine if
there were differences between the groups. Statis-
tical significance was set at P , .05. Model 1 used a repeated measures analysis to compare changes
in nausea score preintervention and postinterven-
tion. Model 2 examined total length of stay in relation to inhaler fragrance and intraoperative
medications. Unadjusted analysis of variance
was also conducted to determine any changes in
preoperative and postoperative nausea assessment
scores between the three intervention arms. A
power analysis was conducting using a 5 0.05 and b 5 0.20 determined a sample size of 190 was needed; therefore this study was adequately powered.
Results
Overall 322 same day surgical patients were analyzed (control group [n 5 179] and interven- tion group [n 5 143]). Among the eight hospital adult services, most patients (70%) came from
three services including urology, neurosurgery,
and general or trauma.
Among the six variables (age, gender, race, epi-
sodes of PONV, total hours in the operating room, and average number of doses of antiemetics
administered) all were statically different between
the control and the intervention groups, except
age and gender. It should be noted that subjects
in the intervention group were predominantly
White, had a greater history of PONV, and received
fewer doses of antiemetics postoperatively
(Table 1). Those who used an antiemetic and those who had a history of postoperative nausea had
greater preimprovement to postimprovement in
nausea scores after controlling for the other vari-
ables in the model. This model accounted for
20% of the variance in nausea change scores
(Table 2). Those who spent 2 hours or greater in
the operating room had longer length of stay in
the surgical center compared with those less than 2 hours after controlling for the other vari-
ables in the model. This model accounted for
13% of the variance in length of stay (Table 3).
Within the intervention group (�45% of total sample), the three types of essential oils included
peppermint, ginger, and a combination of both,
the distribution was 16%, 17%, and 12%, respectively, whereas the control group consti-
tuted �55% of the total sample. There was no
Table 1. Control Versus Intervention for Essential Oils to Reduce PONV (n 5 322)
Control (n 5 179) Intervention (n 5 143) P Value
Age x 6 SD 55.18 6 17.53 54.64 6 15.89 .774 Sex Female 5 87 (48.6%) Female 5 71 (49.7%) .85
Male 5 92 (51.4%) Male 5 72 (50.3%) Race (%, n) Caucasian 5 76.5% (137) Caucasian 5 90.9% (130) .002
African American 5 15.1% (27) African American 5 6.3% (9) Hispanic/Latino 5 6.1% (11) Hispanic/Latino 5 0.7% (1) Other 5 2.2% (4) Other 5 2.1% (3)
History PONV Yes 5 4.5% (8) Yes 5 14.0% (20) .003 No 5 95.5% (171) No 5 86.0% (123)
Number of PONV episodes
per patient x 6 SD 0.54 6 0.90 1.72 6 1.80 , .001
Number of doses of antiemetics
per patient x 6 SD 0.53 6 0.85 0.15 6 0.47 , .001
PONV, postoperative nausea and vomiting.
ESSENTIAL OILS FOR NAUSEA AND VOMITING 5
statistically significant difference in the type of
inhaler used (P 5 .62). A separate unadjusted anal- ysis of variance produced similar results, support-
ing the previous findings. During the study, no
complications or adverse reactions occurred.
Although anecdotal information was not systemat-
ically collected or studied, comments from the nurses included ‘‘.patients were happy with their inhaler.,’’ ‘‘.wouldn’t give me the inhaler back, but promised to tell me when it was used.,’’ and ‘‘I’m certain I gave fewer doses of intravenous
antiemetics during the study period.’’ In addition,
on more than one occasion, patients’ comments
included ‘‘I love my inhaler,’’ ‘‘can I do this again
next time I have surgery?’’, and ‘‘I want my (eg, child, niece, husband) to try this for their car sick-
ness.’’ One study participant commented ‘‘I don’t
Table 2. Repeated Measures Analysis—
Variable B (SE) t Va
Age 0.001 (0.01) 0
Sex 0.13 (0.36) 0
Race 0.19 (0.83) 0
Total number of hours OR 20.34 (0.28) 21 Number of intraoperative medicines 20.39 (0.25) 21 History of PONV 0.77 (0.38) 2
Type of inhaler 20.10 (0.20) 20 Antiemetic used 1.25 (0.60) 2
Inhaler 3 antiemetic 20.34 (0.33) 21
CI, confidence interval; OR, operating room; PONV, posto
scale.
Model: R 2 5 0.20, F 5 1.54, P 5 .16.
like the smell, but it seemed to work anyway.’’
Also, several patients that either declined to partic-
ipate in the study or were never approached re-
quested to use a nasal inhaler when they
experienced PONV, and the IV antiemetics were
unsuccessful in relieving their symptoms. In all
cases, those patients experienced decreased symp-
toms and expressed satisfaction with the nasal inhaler. None of those patients were included in
the study data.
Discussion
This nurse-led study demonstrated that patients
who receive aromatherapy postoperatively
for nausea have fewer antiemetics in the adult
hospital ambulatory or 23-hour surgical patient
as compared with the control group; in addition,
Changes in Nausea (VDS) Scale
lue P Value 95% CI Lower 95% CI Upper
.12 .90 20.02 0.02
.38 .71 20.55 0.80
.23 .82 21.47 1.85
.23 .22 20.90 0.22
.56 .13 20.90 0.11
.05 .05 0.02 1.53
.50 .62 20.50 0.30
.08 .04 0.05 2.45
.05 .30 20.99 0.31
perative nausea and vomiting; VDS, verbal descriptive
Table 3. Length of Stay Comparison
Variable B (SE) t value P Value 95% CI Lower 95% CI Upper
Sex 2.09 (2.83) 0.74 .46 23.58 7.77 Ethnicity 2.42 (7.00) 0.35 .73 211.60 16.45 Age 0.06 (0.08) 0.79 .43 20.10 0.23 Total number of hours in OR 4.48 (2.36) 1.90 .06 20.24 9.20 Number of intraoperative medicines 2.98 (2.13) 1.40 .17 21.29 7.25 History of PONV 0.96 (3.19) 0.30 .77 25.44 7.35 Type of inhaler 0.74 (1.70) 0.44 .66 22.67 4.16 Antiemetic used 22.76 (5.07) 20.54 .59 212.91 7.40 Inhaler 3 antiemetic 1.47 (2.75) 0.54 .59 24.03 6.98
CI, confidence interval; OR, operating room; PONV, postoperative nausea and vomiting.
Model: R 2 5 0.13, F 5 0.93, P 5 .51.
6 FEARRINGTON, QUALLS, AND CAREY
all three arms (peppermint, ginger, and a combina- tion) demonstrated a reduction in the need for an-
tiemetics. Among the three types of essential oils,
they were evenly distributed indicating that the
randomization of the inhalers was effective.
The rate for PONV in this study was approximately
27%, which is consistent with national rates,
which is approximately 30%. 16
Thus, it is recom- mended to use a simplified risk score for PONV
created by Apfel et al, 17
which evaluates adults
preoperatively, so that preventive strategies like
essential oils can be offered to high-risk patients.
The components of the simplified risk score
include the following four highly predictive risk
factors: female gender, nonsmoker, history of
PONV, and expected administration of postopera- tive opioids. On the basis of the number of risk fac-
tors present, 0, 1, 2, 3, and 4, the corresponding
risk of PONV is 10%, 20%, 40%, 60%, and 80%,
respectively.
PONV continues to plague many postoperative
patients, with traditional IV medication not always
a reliable option. Aromatherapy has shown suc- cess as an adjunct therapy for managing PONV
symptoms. QueaseEASE is highly promoted in
perianesthesia literature; however, it is at a much
higher price-point than the inhalers used in this
study. The inhalers used in this study were an
inexpensive alternative, albeit, required a trained
nurse to prepare them for patient use.
Strengths and Limitations
This study was a prospective, double-blind
randomized clinical trial that was designed and
implemented by nurses. Neither the subjects nor investigators knew which of the three-arm inter-
vention was to be used until the subject selected
the nasal inhaler. The low cost of the inhalers
and essential oils was also the strength of the study,
with the net cost being approximately $0.50 each,
and the subjects could take it home with them.
In fact, hospital pharmacies may be able to manu-
facture the inhalers at even lower costs. This study was nurse-led and developed and was supported
by the Department of Anesthesia as well as
the hospital-based Nursing Practice Research
Internship.
Limitations in the research design included using a
convenience sample and a retrospective chart re-
view for the control group rather than a placebo, as well as variability within nursing practice.
Nausea is routinely assessed in the postoperative
patient population; however, the measurement
tool used in this study was new, and therefore
there was a certain learning curve associated
with it. There were also inequitabilities between
the two groups, for example race. Because the con-
trol group had no exclusion criteria, as long as they met the inclusion criteria of being a same day or
23-hour stay patient, non-English speaking pa-
tients were included in the control group. Also, it
was not always well documented in the electronic
medical record when patients had a history of
PONV, which may have led to an inequality be-
tween groups. Although the number and type of
intraoperative antiemetics were collected and controlled for, the type of anesthesia agent was
not addressed in the analysis plan. Finally,
selection of patients based on surgical type and
postoperative assignment (same day or 23-hour
ESSENTIAL OILS FOR NAUSEA AND VOMITING 7
stay) excluded many individuals who may have
benefited from the intervention.
Future Studies
Further studies should be conducted to expand
the patient population to include those surgical
patients that are admitted to the hospital. Use
of a placebo group would strengthen the study
design; however, using an inhaler without any
fragrance would alert the subject and may cause
increased patient anxiety. However, use of a
placebo with a scent that is not an essential oil (such as lemon juice) could prove to be more
effective in forthcoming study development. It
may also be beneficial to allow the nasal inhalers
to be patient-controlled, and rather than assessing
the nausea score preintervention and postinter-
vention, simply document the number of doses
of antiemetics administered. In addition, under-
standing nurses, patients, and families’ satisfaction
with nonpharmacologic interventions would
contribute to the literature.
Conclusions
When properly prepared and using the correct
essential oil(s), aromatherapy should be consid-
ered for most of adult postoperative patients. It is
cost effective, reduces the need for nursing time
and costly, often sedating, medications, and in- creases patient satisfaction.
Acknowledgments
This study would not have been possible without a great deal
of support, especially from the Associate Director of Periopera-
tive Services, Janet Remizowski, the entire team of nurses in
the Surgical Center and Postanesthesia Care Unit, statistical sup-
port from Kim Arcoleo, PhD, MPH, with a special thanks to the
small group of nurses who aided in recruitment and consenting
of subjects (Christine Deitrick, Sandra Price, Kim Veil, and
Casey Sehlin) as well